封面
市場調查報告書
商品編碼
1705626

按資料類型、應用程式、最終使用者和地區分類的去識別健康資料市場

De-identified Health Data Market, By Type of Data, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球去識別健康數據市場規模估計為 82.1 億美元,預計到 2032 年將達到 153.1 億美元,2025 年至 2032 年的複合年成長率為 9.3%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 82.1億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年複合年成長率: 9.30% 2032年價值預測 153.1億美元
數字。 2025年各地區去識別化健康數據市場佔有率(%)
去識別化健康數據市場-IMG1

去識別化醫療數據市場的成長受到藥物發現和精準醫療研發活動不斷增加的推動。去識別化透過從健康資料集中刪除姓名、出生日期和社會安全號碼等識別碼來確保病患的隱私和機密性。這將使研究人員和生命科學公司能夠利用大量健康數據來開發新的治療方法和流行病學研究,而不會損害道德。隨著全球健康記錄數位化的加快,可供二次利用的去識別資料量將會增加。

市場動態

對基於價值的護理、個人化治療和數位健康新興企業的成長的日益關注可能會推動全球對去識別化醫療數據的需求。然而,缺乏數據標準化和智慧財產權模糊性可能會阻礙市場潛力的發揮。高階分析能力的發展為企業提供了從其匯集的數據資產中獲得更深入見解的機會。擴大政府開放資料共用舉措可以擴大對這些資料集的存取。美國政府推出了Data.gov和HealthData.gov等舉措,開放廣泛的健康相關資料集,以促進公共衛生研究的透明度和創新。

本研究的主要特點

本報告對全球去識別化健康數據市場進行了詳細分析,並提供了預測期(2025-2032 年)的市場規模(十億美元)和年複合成長率(CAGR%),假設基準年為 2024 年。

它還強調了各個領域的潛在商機,並解釋了該市場的引人注目的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數,對全球去識別健康數據市場中的主要企業進行了概述。

研究涉及的主要企業包括 IQVIA、 Oracle(Cerner Corporation)、Merative(Truven Health Analytics)、Optum, Inc.、BioTelemetry, Inc.、Flatiron Health、Veradigm LLC、Medidata Solutions、Evidation Health, Inc.、Komodo Health, Inc.、Sundown Solutions, LLC、Clarify Solutions、Akator Cyber​​Ltd.、Tempus、nference、Ciox Health、HealthVerity、Zebra Medical Vision 和 Huma Therapeutics。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球去識別健康數據市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。

相關人員可以透過用於分析全球去識別醫療數據市場的各種策略矩陣來簡化決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 促進要素
  • 限制因素
  • 機會
  • 影響分析
  • 主要進展
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景
  • 產業趨勢

4. 2020 年至 2032 年按資料類型分類的去識別化健康資料市場

  • 臨床數據
  • 基因組數據
  • 患者人口統計
  • 處方數據
  • 帳單數據
  • 行為數據
  • 穿戴式裝置和感測器數據
  • 調查和患者報告數據
  • 影像資料
  • 檢查數據
  • 健康社會決定因素 (SDOH) 數據
  • 其他

5. 2020 年至 2032 年去識別化健康資料市場(依應用分類)

  • 臨床研究與試驗
  • 公共衛生
  • 精準醫療
  • 健康經濟學與成果研究(HEOR)
  • 人口健康管理
  • 藥物研發
  • 提高醫療保健品質
  • 核保和風險評估
  • 其他

6. 2020 年至 2032 年去識別化健康資料市場(依最終使用者分類)

  • 製藥公司
  • 生技公司
  • 醫療保健提供者
  • 保險公司/醫療保健支付者
  • 研究組織
  • 政府
  • 其他

7. 2020 年至 2032 年各地區去識別化健康資料市場

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭態勢

  • IQVIA
  • Oracle(Cerner Corporation)
  • Merative(Truven Health Analytics)
  • Optum, Inc.
  • BioTelemetry, Inc.
  • Flatiron Health
  • Veradigm LLC
  • Medidata Solutions
  • Evidation Health, Inc.
  • Komodo Health, Inc.
  • Sundown Solutions, LLC
  • Clarify Health Solutions
  • Akrivia Health
  • Satori Cyber Ltd.
  • Tempus
  • nference
  • Ciox Health
  • HealthVerity
  • Zebra Medical Vision
  • Huma Therapeutics

第9章分析師建議

  • 命運之輪
  • 分析師觀點
  • 一致的機會圖

第10章參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI7476

Global De-identified Health Data Market is estimated to be valued at USD 8.21 Bn in 2025 and is expected to reach USD 15.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.21 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.30% 2032 Value Projection: USD 15.31 Bn
Figure. De-identified Health Data Market Share (%), By Region 2025
De-identified Health Data Market - IMG1

De-identified health data market growth is driven by increasing research and development activities for drug discovery and precision medicine. De-identification ensures patient privacy and confidentiality by removing identifiers such as name, date of birth, social security number, and others from health data sets. This allows researchers and life science companies to utilize large pools of health data for developing novel therapies and epidemiological studies without compromising on ethics. As digitization of health records accelerates across the world, there will be increase in amount of de-identified data available for secondary usage.

Market Dynamics

Rising focus on value-based care, personalization of treatment, and growth of digital health startups can boost demand for de-identified health data globally. However, lack of data standardization and ambiguity over intellectual property rights can hamper the market potential. Development of advanced analytics capabilities offers an opportunity for players to unlock deeper insights from pooled data assets. Growing open data sharing initiatives by governments can widen the access to these data sets. The U.S. government has launched initiatives like Data.gov and HealthData.gov that offers open access to a wide range of health-related datasets to encourage transparency and innovation in public health research.

Key features of the study

This report provides in-depth analysis of the global de-identified health data market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global de-identified health data market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IQVIA, Oracle (Cerner Corporation), Merative (Truven Health Analytics), Optum, Inc., BioTelemetry, Inc., Flatiron Health, Veradigm LLC, Medidata Solutions, Evidation Health, Inc., Komodo Health, Inc., Sundown Solutions, LLC, Clarify Health Solutions, Akrivia Health, Satori Cyber Ltd., Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, and Huma Therapeutics

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global de-identified health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global de-identified health data market

Market Segmentation

  • Type of Data Insights (Revenue, USD Bn, 2020 - 2032)
    • Clinical Data
    • Genomic Data
    • Patient Demographics
    • Prescription Data
    • Claims Data
    • Behavioral Data
    • Wearable and Sensor Data
    • Survey and Patient-Reported Data
    • Imaging Data
    • Laboratory Data
    • Social Determinants of Health (SDOH) Data
    • Others
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Clinical Research and Trials
    • Public Health
    • Precision Medicine
    • Health Economics and Outcomes Research (HEOR)
    • Population Health Management
    • Drug Discovery and Development
    • Healthcare Quality Improvement
    • Insurance Underwriting and Risk Assessment
    • Others
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Pharmaceutical Companies
    • Biotechnology Firms
    • Healthcare Providers
    • Insurance Companies/Healthcare Payers
    • Research Institutions
    • Government Agencies
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • IQVIA
    • Oracle (Cerner Corporation)
    • Merative (Truven Health Analytics)
    • Optum, Inc.
    • BioTelemetry, Inc.
    • Flatiron Health
    • Veradigm LLC
    • Medidata Solutions
    • Evidation Health, Inc.
    • Komodo Health, Inc.
    • Sundown Solutions, LLC
    • Clarify Health Solutions
    • Akrivia Health
    • Satori Cyber Ltd.
    • Tempus
    • nference
    • Ciox Health
    • HealthVerity
    • Zebra Medical Vision
    • Huma Therapeutics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • De-identified Health Data Market, By Type of Data
    • De-identified Health Data Market, By Application
    • De-identified Health Data Market, By End User
    • De-identified Health Data Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. De-identified Health Data Market, By Type of Data, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Genomic Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Patient Demographics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prescription Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Claims Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Behavioral Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Wearable and Sensor Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Survey and Patient-Reported Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Imaging Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Laboratory Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Social Determinants of Health (SDOH) Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. De-identified Health Data Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Research and Trials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Public Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Precision Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Health Economics and Outcomes Research (HEOR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Population Health Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Healthcare Quality Improvement
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Insurance Underwriting and Risk Assessment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. De-identified Health Data Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology Firms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Healthcare Providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Insurance Companies/Healthcare Payers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Government Agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. De-identified Health Data Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive landscape

  • IQVIA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oracle (Cerner Corporation)
  • Merative (Truven Health Analytics)
  • Optum, Inc.
  • BioTelemetry, Inc.
  • Flatiron Health
  • Veradigm LLC
  • Medidata Solutions
  • Evidation Health, Inc.
  • Komodo Health, Inc.
  • Sundown Solutions, LLC
  • Clarify Health Solutions
  • Akrivia Health
  • Satori Cyber Ltd.
  • Tempus
  • nference
  • Ciox Health
  • HealthVerity
  • Zebra Medical Vision
  • Huma Therapeutics

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us